Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | AGIO |
---|---|---|
09:32 ET | 4515 | 48.68 |
09:34 ET | 1592 | 47.9184 |
09:36 ET | 100 | 48.14 |
09:38 ET | 2331 | 48.195 |
09:39 ET | 122 | 48.06 |
09:41 ET | 970 | 48.34 |
09:43 ET | 400 | 48.4 |
09:45 ET | 300 | 48.34 |
09:48 ET | 3673 | 48.245 |
09:50 ET | 927 | 48.27 |
09:52 ET | 900 | 48.405 |
09:54 ET | 700 | 48.25 |
09:56 ET | 300 | 48.24 |
09:57 ET | 1978 | 48.13 |
09:59 ET | 4103 | 47.61 |
10:01 ET | 320 | 47.7 |
10:03 ET | 725 | 47.8 |
10:06 ET | 300 | 47.79 |
10:08 ET | 300 | 47.89 |
10:10 ET | 1324 | 48.08 |
10:12 ET | 300 | 48.155 |
10:15 ET | 100 | 48.215 |
10:17 ET | 817 | 48.135 |
10:19 ET | 5813 | 48.21 |
10:21 ET | 519 | 48.31 |
10:24 ET | 593 | 48.255 |
10:26 ET | 300 | 48.31 |
10:28 ET | 2254 | 48.23 |
10:30 ET | 1700 | 48.255 |
10:32 ET | 1890 | 48.215 |
10:33 ET | 7179 | 48.48 |
10:35 ET | 900 | 48.35 |
10:37 ET | 341 | 48.4 |
10:39 ET | 695 | 48.4 |
10:42 ET | 300 | 48.45 |
10:46 ET | 1475 | 48.46 |
10:48 ET | 1325 | 48.49 |
10:50 ET | 300 | 48.44 |
10:51 ET | 7808 | 48.57 |
10:53 ET | 273 | 48.67 |
10:55 ET | 1600 | 48.62 |
10:57 ET | 300 | 48.5 |
11:00 ET | 300 | 48.495 |
11:02 ET | 18282 | 48.03 |
11:04 ET | 2482 | 48.175 |
11:06 ET | 1500 | 48.23 |
11:08 ET | 300 | 48.16 |
11:09 ET | 100 | 48.14 |
11:11 ET | 1600 | 48.32 |
11:13 ET | 100 | 48.37 |
11:15 ET | 1543 | 48.46 |
11:18 ET | 700 | 48.55 |
11:22 ET | 2220 | 48.66 |
11:24 ET | 2471 | 48.58 |
11:26 ET | 1200 | 48.55 |
11:27 ET | 623 | 48.58 |
11:29 ET | 400 | 48.565 |
11:31 ET | 500 | 48.595 |
11:36 ET | 360 | 48.58 |
11:38 ET | 1500 | 48.7 |
11:40 ET | 200 | 48.78 |
11:42 ET | 2000 | 48.63 |
11:44 ET | 11037 | 48.83 |
11:45 ET | 1297 | 48.81 |
11:47 ET | 2644 | 48.68 |
11:49 ET | 1000 | 48.685 |
11:51 ET | 600 | 48.665 |
11:54 ET | 300 | 48.63 |
11:56 ET | 600 | 48.565 |
11:58 ET | 1472 | 48.54 |
12:00 ET | 1448 | 48.67 |
12:02 ET | 600 | 48.6599 |
12:03 ET | 200 | 48.64 |
12:05 ET | 400 | 48.585 |
12:07 ET | 2410 | 48.575 |
12:09 ET | 2200 | 48.575 |
12:12 ET | 1300 | 48.6 |
12:14 ET | 2227 | 48.49 |
12:16 ET | 900 | 48.42 |
12:18 ET | 400 | 48.455 |
12:20 ET | 1927 | 48.315 |
12:21 ET | 179 | 48.2401 |
12:23 ET | 100 | 48.17 |
12:25 ET | 500 | 48.19 |
12:27 ET | 100 | 48.21 |
12:32 ET | 438 | 48.16 |
12:34 ET | 1265 | 48.22 |
12:36 ET | 100 | 48.255 |
12:38 ET | 200 | 48.21 |
12:39 ET | 200 | 48.25 |
12:41 ET | 416 | 48.23 |
12:43 ET | 600 | 48.275 |
12:45 ET | 9337 | 48.4 |
12:48 ET | 2620 | 48.449 |
12:50 ET | 600 | 48.45 |
12:52 ET | 2520 | 48.45 |
12:54 ET | 100 | 48.4 |
12:56 ET | 3918 | 48.2801 |
12:57 ET | 1500 | 48.38 |
12:59 ET | 200 | 48.32 |
01:01 ET | 200 | 48.3275 |
01:03 ET | 1355 | 48.378 |
01:06 ET | 1361 | 48.32 |
01:10 ET | 500 | 48.26 |
01:12 ET | 1331 | 48.33 |
01:15 ET | 530 | 48.355 |
01:17 ET | 100 | 48.345 |
01:19 ET | 500 | 48.36 |
01:21 ET | 2492 | 48.41 |
01:24 ET | 1500 | 48.38 |
01:26 ET | 1300 | 48.4 |
01:28 ET | 40362 | 48.112 |
01:30 ET | 200 | 48.19 |
01:32 ET | 680 | 48.12 |
01:33 ET | 208 | 48.02 |
01:35 ET | 100 | 48.05 |
01:37 ET | 249 | 48.07 |
01:39 ET | 700 | 48.15 |
01:42 ET | 300 | 48.18 |
01:44 ET | 300 | 48.205 |
01:46 ET | 500 | 48.23 |
01:48 ET | 1495 | 48.19 |
01:50 ET | 300 | 48.16 |
01:51 ET | 500 | 48.18 |
01:53 ET | 800 | 48.145 |
01:55 ET | 1112 | 48.175 |
01:57 ET | 1000 | 48.18 |
02:00 ET | 307 | 48.21 |
02:02 ET | 300 | 48.23 |
02:04 ET | 1430 | 48.19 |
02:06 ET | 500 | 48.195 |
02:08 ET | 900 | 48.135 |
02:09 ET | 1500 | 48.165 |
02:11 ET | 1893 | 48.22 |
02:15 ET | 2186 | 48.225 |
02:18 ET | 100 | 48.235 |
02:20 ET | 300 | 48.22 |
02:22 ET | 300 | 48.25 |
02:24 ET | 200 | 48.24 |
02:26 ET | 1381 | 48.305 |
02:27 ET | 452 | 48.3 |
02:29 ET | 1000 | 48.26 |
02:31 ET | 430 | 48.258 |
02:36 ET | 3504 | 48.17 |
02:38 ET | 2547 | 48.275 |
02:40 ET | 1166 | 48.275 |
02:42 ET | 300 | 48.25 |
02:44 ET | 1588 | 48.24 |
02:45 ET | 1240 | 48.2 |
02:47 ET | 1300 | 48.16 |
02:49 ET | 1643 | 48.24 |
02:51 ET | 1050 | 48.18 |
02:54 ET | 1700 | 48.18 |
02:56 ET | 4516 | 48.05 |
02:58 ET | 3282 | 48 |
03:00 ET | 1595 | 48.03 |
03:02 ET | 2552 | 47.965 |
03:03 ET | 2526 | 47.96 |
03:05 ET | 200 | 47.97 |
03:07 ET | 1300 | 47.9525 |
03:09 ET | 2529 | 47.84 |
03:12 ET | 2640 | 47.82 |
03:14 ET | 2359 | 47.81 |
03:16 ET | 5298 | 47.815 |
03:18 ET | 757 | 47.78 |
03:20 ET | 3107 | 47.73 |
03:21 ET | 1052 | 47.735 |
03:23 ET | 2818 | 47.7815 |
03:25 ET | 1300 | 47.82 |
03:27 ET | 700 | 47.83 |
03:30 ET | 3274 | 47.93 |
03:32 ET | 700 | 47.9 |
03:34 ET | 4050 | 47.84 |
03:36 ET | 3951 | 47.77 |
03:38 ET | 1137 | 47.75 |
03:39 ET | 1000 | 47.71 |
03:41 ET | 7046 | 47.85 |
03:43 ET | 12288 | 47.825 |
03:45 ET | 8585 | 47.79 |
03:48 ET | 2424 | 47.765 |
03:50 ET | 4789 | 47.79 |
03:52 ET | 14527 | 47.86 |
03:54 ET | 8142 | 47.88 |
03:56 ET | 21068 | 47.765 |
03:57 ET | 21002 | 47.79 |
03:59 ET | 37918 | 47.8 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Agios Pharmaceuticals Inc | 2.1B | -7.6x | --- |
Intellia Therapeutics Inc | 2.1B | -4.3x | --- |
Vera Therapeutics Inc | 2.1B | -18.6x | --- |
Recursion Pharmaceuticals Inc | 2.0B | -5.6x | --- |
Geron Corp | 2.1B | -11.2x | --- |
Celldex Therapeutics Inc | 2.2B | -12.3x | --- |
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and delivering transformative therapies for patients living with rare diseases. It markets a first-in-class pyruvate kinase (PK) activator for adults with PK deficiency, the first disease-modifying therapy for debilitating hemolytic anemia. Its lead product candidate in its genetically defined disease (GDD) portfolio, PYRUKYND (Mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the treatment of hemolytic anemias. The Mitapivat is an orally available small molecule and a potent activator of the pyruvate kinase R (PKR) enzymes. In addition, it is also evaluating mitapivat for the treatment of alpha- and beta- thalassemia and sickle cell disease (SCD) in ongoing clinical trials. The Company is also developing AG-946, a clinical-stage oral activator of PKR enzymes for the treatment of hemolytic anemias and other indications, including SCD.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.1B |
---|---|
Revenue (TTM) | $29.4M |
Shares Outstanding | 56.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.77 |
EPS | $-6.31 |
Book Value | $14.50 |
P/E Ratio | -7.6x |
Price/Sales (TTM) | 70.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,336.42% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.